ONE Bio Corp. (ONBI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2010 | 27.49 Million USD | 27.58% |
| 2009 | 21.55 Million USD | 27895.54% |
| 2008 | 76.98 Thousand USD | -41.45% |
| 2007 | 131.48 Thousand USD | 49.94% |
| 2006 | 87.69 Thousand USD | 82.34% |
| 2005 | 48.09 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2011 Q1 | 30.83 Million USD | 12.13% |
| 2011 Q3 | 33.57 Million USD | 18.58% |
| 2011 Q2 | 28.31 Million USD | -8.16% |
| 2010 Q3 | 28.76 Million USD | 12.12% |
| 2010 Q2 | 25.65 Million USD | -1.63% |
| 2010 FY | 27.49 Million USD | 27.58% |
| 2010 Q1 | 26.07 Million USD | 21.0% |
| 2010 Q4 | 27.49 Million USD | -4.4% |
| 2009 Q2 | 4.00 USD | -100.0% |
| 2009 Q4 | 21.55 Million USD | 28.65% |
| 2009 FY | 21.55 Million USD | 27895.54% |
| 2009 Q1 | 86.94 Thousand USD | 12.94% |
| 2009 Q3 | 16.75 Million USD | 418785775.0% |
| 2008 FY | 76.98 Thousand USD | -41.45% |
| 2008 Q3 | 73.32 Thousand USD | 4.68% |
| 2008 Q4 | 76.98 Thousand USD | 4.99% |
| 2008 Q2 | 70.03 Thousand USD | 2.65% |
| 2008 Q1 | 68.23 Thousand USD | -48.11% |
| 2007 FY | 131.48 Thousand USD | 49.94% |
| 2007 Q2 | 75.81 Thousand USD | -3.11% |
| 2007 Q3 | 69.28 Thousand USD | -8.62% |
| 2007 Q4 | 131.48 Thousand USD | 89.79% |
| 2007 Q1 | 78.25 Thousand USD | -10.77% |
| 2006 Q4 | 87.69 Thousand USD | 0.0% |
| 2006 FY | 87.69 Thousand USD | 82.34% |
| 2005 FY | 48.09 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -100128.958% |
| Arch Therapeutics, Inc. | 9.46 Million USD | -190.472% |
| Evofem Biosciences, Inc. | 72.47 Million USD | 62.06% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -3299.606% |
| Rebus Holdings, Inc. | 5.24 Million USD | -424.529% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | 53.408% |
| Qrons Inc. | 1.48 Million USD | -1746.952% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 1.22 Million USD | -2142.336% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | 63.3% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -61417.384% |
| Skye Bioscience, Inc. | 14.07 Million USD | -95.391% |
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | 48.418% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | -186.952% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -6422.272% |
| SQZ Biotechnologies Company | 50.03 Million USD | 45.051% |
| Intellipharmaceutics International Inc. | 12 Million USD | -128.964% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -613.913% |
| Mesoblast Limited | 188.44 Million USD | 85.409% |
| Marizyme, Inc. | 26.67 Million USD | -3.074% |
| Genus plc | 485 Million USD | 94.331% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -370.607% |
| Pharming Group N.V. | 244.07 Million USD | 88.735% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -1267.862% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -992.696% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -623.574% |
| ContraFect Corporation | 32.53 Million USD | 15.478% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -1287.761% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -618.347% |
| IMV Inc. | 37.93 Million USD | 27.514% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | -133.447% |
| MultiCell Technologies, Inc. | 1617.67 USD | -1699616.877% |
| Accustem Sciences Inc. | 1.07 Million USD | -2447.704% |
| RVL Pharmaceuticals plc | 77.41 Million USD | 64.483% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 2.11 Million USD | -1199.996% |
| Q BioMed Inc. | 8.13 Million USD | -238.08% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | 66.847% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -434.311% |
| Biomind Labs Inc. | 1.49 Million USD | -1734.752% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | 76.84% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | -204.083% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | -49.406% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -1817.606% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -19250.301% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -13571.617% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -378.536% |
| GB Sciences, Inc. | 5.41 Million USD | -407.532% |
| Alpha Cognition Inc. | 7.16 Million USD | -283.764% |
| HST Global, Inc. | 593.59 Thousand USD | -4532.098% |
| CSL Limited | 18.62 Billion USD | 99.852% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -2083.606% |
| Halberd Corporation | 728.71 Thousand USD | -3673.17% |
| Enzolytics Inc. | 365.26 Million USD | 92.472% |
| Agentix Corp. | 2.51 Million USD | -995.208% |
| Resverlogix Corp. | 67.39 Million USD | 59.203% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -3178.259% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 444.95 Million USD | 93.82% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -1504.19% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | -11.112% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | -130.997% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -650.193% |
| AVAX Technologies, Inc. | 3.99 Million USD | -588.472% |
| Zenith Capital Corp. | 27.56 Thousand USD | -99634.521% |
| Genscript Biotech Corporation | 1.32 Billion USD | 97.926% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -11421.202% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -636.303% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -3938.548% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -913.992% |
| Kadimastem Ltd | 3.5 Million USD | -684.504% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -40982.057% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 50.26 Million USD | 45.297% |
| BioStem Technologies, Inc. | 15.9 Million USD | -72.879% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -5816.908% |
| LadRx Corporation | 2.2 Million USD | -1149.51% |
| Cell Source, Inc. | 15.8 Million USD | -73.95% |
| Regen BioPharma, Inc. | 5.45 Million USD | -403.806% |
| Regen BioPharma, Inc. | 5.45 Million USD | -403.806% |
| NovAccess Global Inc. | 7.86 Million USD | -249.787% |
| Affymax, Inc. | 8.87 Million USD | -209.952% |
| Itoco Inc. | 1.65 Million USD | -1563.236% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -1240.236% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -354.551% |
| Mobile Lads Corp. | 1.31 Million USD | -1993.329% |
| CytoDyn Inc. | 127.89 Million USD | 78.501% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -65681.023% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -1655.376% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | -148.937% |
| SYBLEU INC | 681.41 Thousand USD | -3935.117% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -350.61% |
| International Stem Cell Corporation | 5.27 Million USD | -421.05% |
| Bioxytran, Inc. | 3.24 Million USD | -746.155% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -4293.642% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -495.518% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | 32.931% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | -23.493% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -1257.558% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -401.932% |
| Neutra Corp. | 973.52 Thousand USD | -2724.344% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | 5.236% |
| PureTech Health plc | 125.58 Million USD | 78.105% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -631.831% |
| IXICO plc | 1.9 Million USD | -1346.926% |
| IntelGenx Technologies Corp. | 20.52 Million USD | -33.936% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 73.389% |
| CSL Limited | 18.62 Billion USD | 99.852% |
| Cellectis S.A. | 249.36 Million USD | 88.974% |